CapDecisif Management
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B
Geographical Focus
United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Portugal, Sweden, Belgium, Norway, Finland, Poland, Czech Republic, Romania, Bulgaria
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Real Estate
- Telecommunications
- Media
- Retail
- Education
- Agriculture
- Logistics
- Transportation
- Life Sciences
- Digital Health
- Information Technology
- Biotechnology
- Engineering
- Clean Tech
- Environment
Investment Size:
500,000 to 4,000,000 USD
Investor Details
CapDecisif Management is an independent venture capital firm specializing in early-stage investments in technology and healthcare sectors. Since its inception in 2001, the firm has supported over 85 companies across Western Europe, generating consistent returns for its investors. The team is recognized for its complementary skills and extensive network, making them trusted partners for entrepreneurs.
The firm's investment strategy focuses on sectors such as digital health, biotechnology, and engineering, targeting companies with high growth potential. CapDecisif Management manages five funds totaling over €103 million, investing in innovative startups primarily in the Île-de-France region. Their portfolio includes notable companies like Sequans Communications, Echosens, Kynogon, Voluntis, DBV Technologies, Erytech Pharma, Innavirvax, and NanoBiotix, with four of them now listed on the stock exchange.
CapDecisif Management is supported by Bpifrance and the Île-de-France region, reflecting its strong ties to regional development initiatives. The firm's approach combines sectorial risk diversification with cross-sectorial competence, actively supporting entrepreneurs in their strategic decisions and business plan implementation. This methodology has proven effective in fostering the growth of innovative companies in the region.
Investment Requirements: CapDecisif Management seeks to invest in early-stage companies with high growth potential, particularly those in the technology and healthcare sectors. The firm focuses on startups that offer innovative solutions and demonstrate scalability in their respective markets.
Year Founded: 2001
Portfolio Companies: Sequans Communications, Echosens, Kynogon, Voluntis, DBV Technologies, Erytech Pharma, Innavirvax, NanoBiotix
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Mentioned In
-
$19.95
-
$19.95
-
$19.95
-
$14.95
-
$24.95
-
$24.95
-
$24.95
-
$19.95
-
$19.95
-
$245.00
-
$99.00
-
$19.95
-
$24.95
-
$19.95
-
$49.95
Claim this Investor
Are you an official representative of CapDecisif Management?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim